REINJECTION OF INTRAVITREAL TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RAMEZANI ALI REZA; TABATABAEI HOMA; AHMADIEH H.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2005 | Volume:11 | Issue:1 (42) Page(s): 91-99

Download Full-Text

Persian Verion

View:

870

Download:

Cites:

Information Journal Paper

Title

REINJECTION OF INTRAVITREAL TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA

Author(s)

RAMEZANI ALI REZA | TABATABAEI HOMA | AHMADIEH H. | Issue Writer Certificate

Keywords

INTRAVITREAL TRIAMCINOLONEQ3

REINJECTIONQ3

REFRACTORY DIABETIC MACULAR EDEMAQ3

Abstract

Purpose: To evaluate the effect of INTRAVITREAL TRIAMCINOLONE acetonide (IVT) REINJECTION on clinical and optical coherence tomographic (OCT) features in REFRACTORY DIABETIC MACULAR EDEMA (DME).Methods: In an interventional case series, all IVT-treated patients enrolled in a previous clinical trial (45 subjects), were recalled for performing a new ophthalmologic examination and OCT. Suitable eyes for REINJECTION received 4 mg IVT. Complete ophthalmologic examination and OCT were performed after two and four months.Results: From 45 recalled patients, 23 were included for the new study (51.1% response rate). Of these, only 12 cases were considered as candidates for REINJECTION. Visual acuity (VA) changes were not significant in the reinjected eyes after both the first and the second interventions, although there was a relative improvement (0.14 log MAR) at two months after the first injection. Central macular thickness (CMT) was reduced by 27 and 49 m two and four months after the REINJECTION and 43 and 40 m at two and four months after the first injection. None of the mentioned changes was significant. IOP elevation was significant two and four months after the second injection (3.6 and 2.4 mmHg, respectively, P<0.05). However, it was significant (5.58 mmHg, P=0.001) only two months after the first injection.Conclusion: The transient beneficial effects of IVT on refractory DME are not repeated with second injections. However, IVT-related ocular hypertension is more persistent after REINJECTION.

Cites

No record.

References

INTRAVITREAL TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA: A RANDOMIZED CLINICAL TRIAL

Cite

APA: Copy

RAMEZANI, ALI REZA, TABATABAEI, HOMA, & AHMADIEH, H.. (2005). REINJECTION OF INTRAVITREAL TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA. BINA, 11(1 (42)), 91-99. SID. https://sid.ir/paper/42310/en

Vancouver: Copy

RAMEZANI ALI REZA, TABATABAEI HOMA, AHMADIEH H.. REINJECTION OF INTRAVITREAL TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA. BINA[Internet]. 2005;11(1 (42)):91-99. Available from: https://sid.ir/paper/42310/en

IEEE: Copy

ALI REZA RAMEZANI, HOMA TABATABAEI, and H. AHMADIEH, “REINJECTION OF INTRAVITREAL TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA,” BINA, vol. 11, no. 1 (42), pp. 91–99, 2005, [Online]. Available: https://sid.ir/paper/42310/en

Related Journal Papers